Publications by authors named "Francisco Blazquez Molina"
High-dose-rate (2 fractions of 13.5 Gy) and low-dose-rate brachytherapy as monotherapy in prostate cancer. Long term outcomes and predictive value of nadir prostate-specific antigen.
Silvia Rodríguez Villalba Diana Guevara Barrera Luis Suso-Martí Enrique Sanchis-Sánchez Jose Pérez-Calatayud Francisco Blázquez Molina
Brachytherapy
December 2024
Purpose: This study aims to evaluate the outcomes of patients treated for low-risk (LR) and favorable intermediate risk (FIR) prostate cancer with brachytherapy (BT) in monotherapy with LDR or HDR and its relationship with nadir PSA (nPSA).
Materials And Methods: We retrospectively analyzed 139 patients (2005-2019) with exclusive LDR (46%. 145/160 Gy) /HDR (54%.
Impact of MRI-based planning in transperineal interstitial brachytherapy for locally advanced cervix tumors: Clinical, dosimetric and toxicity outcomes.
Diana Guevara Barrera Silvia Rodríguez Villalba Luis Suso-Martí Enrique Sanchis-Sánchez Jose Perez-Calatayud Francisco Blázquez Molina
Brachytherapy
November 2024
Article Synopsis
- The study aimed to compare the effectiveness and safety of different brachytherapy planning methods for treating locally advanced cervical cancer, specifically between CT and MRI-based approaches.
- A total of 106 patients were analyzed, with results indicating no significant difference in survival rates between the two methods, but MRI-based planning with the Template Benidorm resulted in smaller treatment volumes and reduced toxicity.
- The findings suggested that MRI planning allows for better treatment precision, leading to decreased rectal hemorrhage and a trend towards higher doses delivered to the tumor site without increasing overall toxicity.